JMP Securities Maintains Agilon Health(AGL.US) With Hold Rating
Agilon Health Analyst Ratings
Citigroup Upgrades Agilon Health to Buy, Raises Price Target to $5
Analysts Offer Insights on Healthcare Companies: UnitedHealth (UNH), Eli Lilly & Co (LLY) and Agilon Health (AGL)
Truist Financial Maintains Agilon Health(AGL.US) With Hold Rating
Truist Financial Sticks to Their Hold Rating for Agilon Health (AGL)
TD Cowen Maintains Agilon Health(AGL.US) With Hold Rating, Raises Target Price to $6
Agilon Health Is Maintained at Hold by TD Cowen
TD Cowen Maintains Hold on Agilon Health, Raises Price Target to $6
Baird Maintains Neutral on Agilon Health, Lowers Price Target to $5
Balanced Outlook on Agilon Health: Hold Rating Amid Cautious Profitability and Conservative Revenue Growth
Wells Fargo Maintains Agilon Health(AGL.US) With Buy Rating, Raises Target Price to $6
Bernstein Initiates Agilon Health(AGL.US) With Buy Rating, Announces Target Price $8.5
Agilon Health Analyst Ratings
Bernstein Upgrades Agilon Health to Outperform, Raises Price Target to $8.5
Bernstein Reaffirms Their Hold Rating on Agilon Health (AGL)
Needham Maintains Agilon Health(AGL.US) With Hold Rating
Agilon Health Analyst Ratings
Wells Fargo Maintains Agilon Health(AGL.US) With Buy Rating, Maintains Target Price $5
Agilon Health: Strategic Focus and Conservative Guidance Drive Buy Rating Amidst Modest Q4 Improvement